Literature DB >> 630708

Purification of human prostatic acid phosphatase by affinity chromatography and isoelectric focusing. Part I.

P Vihko, M Kontturi, L K Korhonen.   

Abstract

The main isoenzyme of human prostatic acid phosphatases was purified by affinity chromatography on L(+)-tartrate linked to agarose and by isoelectric focusing. The enzyme was a single protein when examined by polyacrylamide gel electrophoreses, either as a native protein or in the presence of sodium dodecyl sulfate. The analytical recovery of enzyme activity was 19%. The specific activity was 40 18 mumol/(min X mg) for hydrolysis of 5.5 mmol/liter p-nitrophenyl phosphate at pH 4.8 and 37 degrees C. The purification factor was as great as 1900. The molecular weight of the enzyme as measured by gel filtration was 109 000 and by polyacrylamide gel electrophoresis in the presence of sodium dodecyl sulfate 54 000, indicating that the enzyme had been isolated in the dimer form. By this method we have achieved the best purification of human prostatic acid phosphatase so far.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 630708

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  10 in total

1.  Rat acid phosphatase: overexpression of active, secreted enzyme by recombinant baculovirus-infected insect cells, molecular properties, and crystallization.

Authors:  P Vihko; R Kurkela; K Porvari; A Herrala; A Lindfors; Y Lindqvist; G Schneider
Journal:  Proc Natl Acad Sci U S A       Date:  1993-02-01       Impact factor: 11.205

2.  Biodistribution in normal mice of an 111In-labelled prostatic acid phosphatase-specific antibody and its F(ab')2 fragments derivatized site-specifically or via bicyclic diethylenetriaminepentaacetic acid anhydride.

Authors:  M Perälä; P Vihko; M Södervall; J Heikkilä; R Vihko
Journal:  Eur J Nucl Med       Date:  1990

3.  Effects of tumour mass and circulating antigen on the biodistribution of 111In-labelled F(ab')2 fragments of human prostatic acid phosphatase monoclonal antibody in nude mice bearing PC-82 human prostatic tumour xenografts.

Authors:  M Perälä-Heape; P Vihko; A Laine; J Heikkilä; R Vihko
Journal:  Eur J Nucl Med       Date:  1991

4.  Homodimer and heterodimer subunits of human prostate acid phosphatase.

Authors:  H Lee; T M Chu; S S Li; C L Lee
Journal:  Biochem J       Date:  1991-08-01       Impact factor: 3.857

5.  Immunologically reactive tryptic fragments of human prostatic acid phosphatase.

Authors:  C L Lee; S S Li; T M Chu
Journal:  Biochem J       Date:  1984-11-01       Impact factor: 3.857

6.  Secretion and N-linked glycosylation are required for prostatic acid phosphatase catalytic and antinociceptive activity.

Authors:  Julie K Hurt; Brendan J Fitzpatrick; Jacqueline Norris-Drouin; Mark J Zylka
Journal:  PLoS One       Date:  2012-02-28       Impact factor: 3.240

Review 7.  Emerging roles of human prostatic Acid phosphatase.

Authors:  Hoon Young Kong; Jonghoe Byun
Journal:  Biomol Ther (Seoul)       Date:  2013-01       Impact factor: 4.634

8.  Prostatic Acid Phosphatase (PAP) Predicts Prostate Cancer Progress in a Population-Based Study: The Renewal of PAP?

Authors:  Huan Xu; Fubo Wang; Huizhen Li; Jin Ji; Zhi Cao; Ji Lyu; Xiaolei Shi; Yasheng Zhu; Chao Zhang; Fei Guo; Ziyu Fang; Bo Yang; Yinghao Sun
Journal:  Dis Markers       Date:  2019-01-23       Impact factor: 3.434

9.  Multifunctionality of prostatic acid phosphatase in prostate cancer pathogenesis.

Authors:  Evgenia Alpert; Armin Akhavan; Arie Gruzman; William J Hansen; Joshua Lehrer-Graiwer; Steven C Hall; Eric Johansen; Sean McAllister; Mittul Gulati; Ming-Fong Lin; Vishwanath R Lingappa
Journal:  Biosci Rep       Date:  2021-10-29       Impact factor: 3.840

10.  Consequences of the lack of CD73 and prostatic acid phosphatase in the lymphoid organs.

Authors:  Gennady G Yegutkin; Kaisa Auvinen; Marika Karikoski; Pia Rantakari; Heidi Gerke; Kati Elima; Mikael Maksimow; Ileana B Quintero; Pirkko Vihko; Marko Salmi; Sirpa Jalkanen
Journal:  Mediators Inflamm       Date:  2014-08-24       Impact factor: 4.711

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.